34 related articles for article (PubMed ID: 24366026)
1. Correlation between the rs7101 and rs1063169 polymorphisms in the FOS noncoding region and susceptibility to and prognosis of colorectal cancer.
Chen H; Ji L; Liu X; Zhong J
Medicine (Baltimore); 2019 Jun; 98(26):e16131. PubMed ID: 31261535
[TBL] [Abstract][Full Text] [Related]
2. CD38 gene polymorphism rs1130169 contribution to the increased gene expression and risk of colorectal cancer (pilot study).
Novikov DV; Perenkov AD; Shumilova SV; Kubysheva NI; Novikov VV
Mol Biol Rep; 2024 Jan; 51(1):63. PubMed ID: 38170288
[TBL] [Abstract][Full Text] [Related]
3. A genome-wide association study for colorectal cancer identifies a risk locus in 14q23.1.
Lemire M; Qu C; Loo LWM; Zaidi SHE; Wang H; Berndt SI; Bézieau S; Brenner H; Campbell PT; Chan AT; Chang-Claude J; Du M; Edlund CK; Gallinger S; Haile RW; Harrison TA; Hoffmeister M; Hopper JL; Hou L; Hsu L; Jacobs EJ; Jenkins MA; Jeon J; Küry S; Li L; Lindor NM; Newcomb PA; Potter JD; Rennert G; Rudolph A; Schoen RE; Schumacher FR; Seminara D; Severi G; Slattery ML; White E; Woods MO; Cotterchio M; Marchand LL; Casey G; Gruber SB; Peters U; Hudson TJ
Hum Genet; 2015 Nov; 134(11-12):1249-1262. PubMed ID: 26404086
[TBL] [Abstract][Full Text] [Related]
4. Identification of specific codon 201 mutation of the DCC Gene in the colonoscopic specimen of colorectal cancer.
Serwer T; Wahid M; Imtiaz F; Memon AS
J Pak Med Assoc; 2024 Feb; 74(2):287-293. PubMed ID: 38419228
[TBL] [Abstract][Full Text] [Related]
5. Evaluating CD4 and Foxp3 mRNA Expression in Tissue Specimens of Celiac Disease and Colorectal Cancer Patients.
Asri N; Nazemalhosseini Mojarad E; Taleghani MY; Houri H; Saeedi Niasar M; Rezaei-Tavirani M; Jahani-Sherafat S; Shahbazkhani A; Nikzamir A; Ehsani Ardakani MJ; Khodadost M; Rostami-Nejad M
Asian Pac J Cancer Prev; 2024 Feb; 25(2):647-652. PubMed ID: 38415552
[TBL] [Abstract][Full Text] [Related]
6. Low-frequency variation in TP53 has large effects on head circumference and intracranial volume.
Haworth S; Shapland CY; Hayward C; Prins BP; Felix JF; Medina-Gomez C; Rivadeneira F; Wang C; Ahluwalia TS; Vrijheid M; Guxens M; Sunyer J; Tachmazidou I; Walter K; Iotchkova V; Jackson A; Cleal L; Huffmann J; Min JL; Sass L; Timmers PRHJ; ; Davey Smith G; Fisher SE; Wilson JF; Cole TJ; Fernandez-Orth D; Bønnelykke K; Bisgaard H; Pennell CE; Jaddoe VWV; Dedoussis G; Timpson N; Zeggini E; Vitart V; St Pourcain B
Nat Commun; 2019 Jan; 10(1):357. PubMed ID: 30664637
[TBL] [Abstract][Full Text] [Related]
7. Potential role of PIN1 genotypes in predicting benefit from oxaliplatin-based and irinotecan-based treatment in patients with metastatic colorectal cancer.
Suenaga M; Schirripa M; Cao S; Zhang W; Yang D; Cremolini C; Lonardi S; Bergamo F; Ning Y; Yamamoto N; Okazaki S; Berger MD; Miyamoto Y; Gopez R; Barzi A; Yamaguchi T; Stintzing S; Heinemann V; Loupakis F; Falcone A; Lenz HJ
Pharmacogenomics J; 2018 Sep; 18(5):623-632. PubMed ID: 29925895
[TBL] [Abstract][Full Text] [Related]
8. P53 mutations occur more commonly than KRAS mutations in colorectal adenoma.
Yan WF; Wu G; Sun PC; Qiu D
Int J Clin Exp Med; 2015; 8(1):1370-5. PubMed ID: 25785139
[TBL] [Abstract][Full Text] [Related]
9. Targeting the Oncogenic p53 Mutants in Colorectal Cancer and Other Solid Tumors.
Li H; Zhang J; Tong JHM; Chan AWH; Yu J; Kang W; To KF
Int J Mol Sci; 2019 Nov; 20(23):. PubMed ID: 31795192
[TBL] [Abstract][Full Text] [Related]
10. The prognostic role of p53 mutations in metastatic colorectal cancer: A systematic review and meta-analysis.
Ottaiano A; Santorsola M; Capuozzo M; Perri F; Circelli L; Cascella M; Ianniello M; Sabbatino F; Granata V; Izzo F; Iervolino D; Casillo M; Petrillo N; Gualillo O; Nasti G; Savarese G
Crit Rev Oncol Hematol; 2023 Jun; 186():104018. PubMed ID: 37150312
[TBL] [Abstract][Full Text] [Related]
11. Association of the p53 codon 72 polymorphism with clinicopathological characteristics of colorectal cancer through mRNA analysis.
De Oliveira LP; López I; Dos Santos EM; Tucci P; Marín M; Soares FA; Rossi BM; Coudry Rde A
Oncol Rep; 2014 Mar; 31(3):1396-406. PubMed ID: 24366026
[TBL] [Abstract][Full Text] [Related]
12. TP53 codon 72 polymorphism and P53 protein expression in colorectal cancer specimens in Isfahan.
Dastjerdi MN
Acta Med Iran; 2011; 49(2):71-7. PubMed ID: 21598212
[TBL] [Abstract][Full Text] [Related]
13. The rs6983267 SNP is associated with MYC transcription efficiency, which promotes progression and worsens prognosis of colorectal cancer.
Takatsuno Y; Mimori K; Yamamoto K; Sato T; Niida A; Inoue H; Imoto S; Kawano S; Yamaguchi R; Toh H; Iinuma H; Ishimaru S; Ishii H; Suzuki S; Tokudome S; Watanabe M; Tanaka J; Kudo SE; Mochizuki H; Kusunoki M; Yamada K; Shimada Y; Moriya Y; Miyano S; Sugihara K; Mori M
Ann Surg Oncol; 2013 Apr; 20(4):1395-402. PubMed ID: 22976378
[TBL] [Abstract][Full Text] [Related]
14. Frequency of TP53 mutations in relation to Arg72Pro genotypes in non small cell lung cancer.
Lind H; Ekstrøm PO; Ryberg D; Skaug V; Andreassen T; Stangeland L; Haugen A; Zienolddiny S
Cancer Epidemiol Biomarkers Prev; 2007 Oct; 16(10):2077-81. PubMed ID: 17932356
[TBL] [Abstract][Full Text] [Related]
15. Genetic alteration of p53, but not overexpression of intratumoral p53 protein, or serum p53 antibody is a prognostic factor in sporadic colorectal adenocarcinoma.
Chang SC; Lin JK; Lin TC; Liang WY
Int J Oncol; 2005 Jan; 26(1):65-75. PubMed ID: 15586226
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
